Trump Makes Major Generic Drug Tariff Announcement
The Pro Patriot News homepage has 60 new headlines every 24 hours - click here to see it.
Donald Trump is rebuilding American Generic Pharmaceutical Production.
Trump announced that all generic drugs being brought into the US will face a 0% tariff for two years.
After two years, the tariff will go to 100% and then a year later 200%.
Trump wrote, “The objective of this Policy is to protect the people of the United States.”
Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter. This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them. The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is. Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America. Thank you for your attention to this matter! President DONALD J. TRUMP
Brand-name pharmaceuticals are going to face tariffs as high as 100% at the end of the month.
This comes after an investigation from the Commerce Department.
The administration has not yet released a formal order imposing the tariffs.
The Trump administration in April announced the results of a Commerce Department investigation into the national security effects of producing drugs overseas. As a result of that probe, brand-name pharmaceuticals will face tariffs as high as 100 percent at the end of the month, but generic drugs are currently excluded from the duties, among a raft of exemptions.
In addition to generic drugs, the administration granted a carveout from the tariffs for companies with plans to build manufacturing plants in the U.S., and set a lower rate for trading partners it has made broader deals with. Major drugmakers including Pfizer, Merck, Bristol Myers Squibb and AstraZeneca also avoided new tariffs on imports after striking their own drug pricing deals with the White House.
Make America Great Again!
